Skip to content Skip to footer

SMURF-Therapeutics, Inc.

Treatments for
cancer, anemia,
and wound healing

SMURF-Therapeutics, Inc.

SMURF-Therapeutics, Inc. is developing small molecule therapeutics to activate or block Smurf2 for cancer, anemia and wound healing. The company was founded by Wafik El-Deiry, MD, PhD, FACP in 2021 to develop small molecule compounds targeting hypoxia responses based on numerous academic research papers and reviews published over 3 decades.

OUR FOCUS

Targeting Hypoxic Responses for Patient Benefits
Treat anemia of chronic disease and myelofibrosis
Increase blood formation
Improve fatigue
For metastatic cancer
Slow tumor growth
Inhibit angiogenesis
Improve health

Get In Touch with SMURF-Therapeutics, Inc.

OUR EXPERTISE

OUR EXPERTISE

Go to Top